When was Lakefront Biotherapeutics founded?

Lakefront Biotherapeutics was founded on 06 Jul 1999, making it 27 years old.

Is Lakefront Biotherapeutics still active?

Yes, Lakefront Biotherapeutics is currently active.

What does Lakefront Biotherapeutics do?

Lakefront Biotherapeutics's registered main activities are Research and experimental development on biotechnology and Research and experimental development on other natural sciences and engineering.

Where is Lakefront Biotherapeutics registered?

Lakefront Biotherapeutics's registered address is Schaliënhoevedreef 20T, 2800 Mechelen, Belgium.

How many employees does Lakefront Biotherapeutics have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2024), Lakefront Biotherapeutics reported 291.5 full-time equivalent employees.

What is Lakefront Biotherapeutics's annual turnover?

Lakefront Biotherapeutics's most recently filed annual turnover (fiscal year ending 31 Dec 2024) was €303,425,198.

Did Lakefront Biotherapeutics make a profit or a loss?

Lakefront Biotherapeutics's most recently filed annual accounts (fiscal year ending 31 Dec 2024) reported a profit of €47,781,908.

When did Lakefront Biotherapeutics last file annual accounts?

Lakefront Biotherapeutics's most recently filed annual accounts cover the fiscal year ending 31 Dec 2024.

Is Lakefront Biotherapeutics B Corp certified?

We have no B Corp certification on file for Lakefront Biotherapeutics.

Does Lakefront Biotherapeutics hold Fairtrade certification?

No, Lakefront Biotherapeutics does not currently hold Fairtrade certification.

Lakefront Biotherapeutics

BE 0466.460.429

Copied!

NV/SA

Status

Active

Founded

06 Jul 1999

Size

Large · 291.5 FTE

Age

27 yrs

Main activity

Research and experimental development on biotechnology

Activities

2 activities

Research and experimental development on biotechnologyResearch and experimental development on other natural sciences and engineering

Financials

Turnover2024

€303M-51.7%

Profit / Loss2024

€47.8M-82.4%

Equity2024

€2.8B+1.7%

2024	2023	2021
€303,425,198-51.7%	€628,899,063+24.9%	€503,389,558
€47,781,908-82.4%	€271,292,107+392.5%	-€92,737,426
€2,829,483,799+1.7%	€2,781,701,891+5.4%	€2,639,924,301
€1,197,120,467-20.5%	€1,505,587,142-39.1%	€2,471,623,002
€60,140,851-13.3%	€69,381,431-94.2%	€1,203,980,495
291.5-20.9%	368.6-24.2%	486.5
€1,040,910-39%	€1,706,183+64.9%	€1,034,716

Frequently asked questions

01What is Lakefront Biotherapeutics's official registered name?

Lakefront Biotherapeutics.

02What is Lakefront Biotherapeutics's enterprise number (VAT number)?

BE 0466.460.429.

03What is Lakefront Biotherapeutics's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2024	2023	2021
Income statement
	€303,425,198-51.7%	€628,899,063+24.9%	€503,389,558
	€57,872,680-21.3%	€73,555,658+4.5%	€70,359,918
	-€207,744,451-401.1%	€68,985,111+136%	-€191,673,681
	€86,331,491	—	€210,169,539
	€345,425,563	—	€306,780,734
	€47,781,908-82.4%	€271,292,107+392.5%	-€92,737,426
	€663,637-71.3%	€2,310,567+41.4%	€1,634,222
Profitability
	28.5%	—	41.8%
	15.7%-63.5%	43.1%+334.2%	-18.4%
	1.7%-82.7%	9.8%+377.6%	-3.5%
	1.2%-81.3%	6.3%+448.3%	-1.8%
Solvency
	€4,044,144,044-6%	€4,301,261,099-16%	€5,120,432,736
	€16,519,206+3.1%	€16,024,739+2.1%	€15,697,366
	€297,493,145+10.8%	€268,399,521+519.6%	€43,317,455
	€2,829,483,799+1.7%	€2,781,701,891+5.4%	€2,639,924,301
	70.0%+8.2%	64.7%+25.4%	51.6%
	—	—	€1,500,000
	—	—	0.00
	€1,197,120,467-20.5%	€1,505,587,142-39.1%	€2,471,623,002
	0.42-21.8%	0.54-42.2%	0.94
	-142.93-939.8%	17.02+228.8%	-13.21
Liquidity
	€60,140,851-13.3%	€69,381,431-94.2%	€1,203,980,495
	€51,191,825-30.8%	€73,978,238+263.3%	€20,360,570
	€32,707,724+21.3%	€26,961,771-71%	€92,851,469
	€92,471,935-28.4%	€129,248,124-13.5%	€149,436,470
	€138,706,338-31.3%	€201,874,356-16.1%	€240,616,552
	2.87+14.8%	2.50+66.3%	1.50
	€2,301,721,872-1.2%	€2,330,808,843-4.9%	€2,450,505,280
Efficiency
	39 days+151.4%	16 days-76.8%	67 days
	89 days-20%	111 days+4.2%	106 days
	403 days-57.2%	940 days+65.2%	569 days
	0.74+21.3%	0.61	—
Profit appropriation
	-€188,142,575+20.3%	-€235,924,484+36.1%	-€369,236,867